Category: savfeabl

Surprise U2/Kanye West Concert In Times Square Tonight, Bruce Springsteen Will Sub For Injured Bono

first_imgLast week, we received unfortunate news that Bono’s biking injury was particularly severe. Though the U2 frontman is expected to fully recover, he will certainly be out of commission for a number of months. However, the band was scheduled to play a surprise concert, tonight, in Times Square, as a charity benefit on World AIDS Day.As they always say, “the show must go on.” The band announced that Bruce Springsteen and Chris Martin (Coldplay) would be filling in for Bono during U2’s set. Also slated to perform are Kanye West and Carrie Underwood.The show will begin at 7:30, and will be broadcast live via YouTube for those unable to attend. Bono was still able to give a statement about the event, saying:“This year is a World AIDS Day like no other. The world reached a tipping point in the fight against AIDS – more people were newly added to life-saving treatment than were newly infected with the virus. A lot of people are calling it the beginning of the end of AIDS. We wouldn’t be at this point without American leadership, people from the left and the right.  Today, 13 million people have access to life-saving treatment, up from 300,000 just over ten years ago.  Americans don’t know the role they’ve played in this fight.  Tonight’s event is to inform them and thank them.”For more information, head to U2’s official website.last_img read more

Truex Jr. extends points lead, but could have had much more

first_imgRELATED: Full race results | Driver standings | Stage points for ’17LOUDON, N.H. — For Coors Light Pole winner Martin Truex Jr., Sunday’s Overton’s 301 had a similar feel to the No. 78 Furniture Row Racing team’s dominating run last weekend at Kentucky — at least for a while.Truex captured the first stage comfortably, increasing his series-best playoff points total to 29 and led the first 78 laps. But there the domination ended.Divergent pit strategies put Truex deep in the field for the start of the second stage, and a flat right front tire forced him to pit out of sequence in the final stage. A poor restart from the bottom lane after the final caution cost him track position, and Truex couldn’t advance beyond third before the checkered flag.The good news? Truex increased his lead in the Monster Energy NASCAR Cup Series standings to 38 points over race runner-up Kyle Larson, who is second in points.“We had a really good WIX Filters Toyota for most of the race and led a bunch of laps and then got that flat tire, kind of got off sequence,” Truex said. “Whatever happened there after Lap 200 or so, I think the VHT (traction compound) was kind of wore off the track, and we started to lose our edge a little bit there. We still had a shot, but on the last restart we got the inside lane there, restarted third. It wasn’t the place to be, obviously.“I think the 11 (race winner Denny Hamlin) started fourth, and that was really the place I would have liked to have been. And then we just didn’t get a good restart on the bottom and lost a couple spots and had to battle back and then just didn’t quite have the speed at the end of the race that we had the first 200 laps. All in all, it was a tough-fought day. We had to come from 24th at one point (at the start of the second stage), and just a hard-fought day, a good job by everybody and a solid third-place effort. Just didn’t have enough there at the end.”last_img read more

3 Injured when Car Hits Conn. Bus Shelter

first_imgBLOOMFIELD, Conn. – Bloomfield officials say three people were seriously injured when their car crashed into a bus stop shelter and rolled over while speeding away from a police detective.Police say two of the three people in the car were ejected during Wednesday afternoon’s wreck on Granby Street. Authorities say a person in the bus shelter at the time wasn’t injured.Authorities haven’t released the victims’ names.Police Capt. Jeffrey Blatter says the car was speeding away from a detective, who noticed that the car matched the description of a vehicle involved in a reported larceny and activated his cruiser’s emergency lights to get by several other cars.Authorities aren’t calling it a police chase, but a regional accident reconstruction team is investigating.___Information from: The Hartford Courant, http://www.courant.comlast_img read more

Get Tightier and Mightier With Skins’ New Compression Cycling Gear

first_imgSKINS was started by an Australian skier in 2002, who spent the previous five years chasing his goal of developing performance and recovery enhancing athletic garments. Their company mission is simple, and perhaps a little cheeky: to radically improve the world of sport, one pair of tights at a time.While there is some debate over the functionality of compression wear, SKINS is clearly on the ‘Pro’ side of the argument. They’re quite happy to cite scientific studies and point out that their garments must be effective since they’re banned from all professional cycling tours! SKINS has a bunch of new compression gear for men and women in their cycling specific line, so click past the break for photos and details… SKINS Tremola Jersey also comes with short or long sleeves, and employs the same construction features and fabrics as the Gottardo jersey but with a different cut that provides a closer fit. It also has the bacteriostatic underarms and three rear pockets, but the Tremola adds a mesh panel on the back for highly efficient cooling. The Tremola long sleeve is $144.99, and comes in black/white or red/black/white. The short sleeve costs $119.99, and has the same color options. Both are available in sizes S-XXL. The Gottardo jersey comes in either a short or long sleeve cut. It uses the SKINdry moisture wicking technology, and partial gradient compression and SKINmuscle+ support in the arms. Overall the jersey provides a looser fit with stretchy areas for comfort and mobility. Bacteriostatic fibres sewn into the armpits reduce odor accumulation and friction, and side mesh panels help you vent. The Gottardo jersey has an elastic bottom hem, full front zipper and three rear pockets with reflective detailing. The long sleeve jersey costs $129.99, and comes in black/white only. The short sleeve version is $104.99, with the option of black/white or emerald green/white. Both come in S-XXL sizes. The women’s Tremola jersey is constructed with partial compression and SKINmuscle+ stability in the arms, SKINdry moisture management, and provides a comfortable SKINfit BMI-based fit. The jersey has a stand-up collar, elastic bottom hem, stretch panels for mobility, odor-reducing armpit fibres, a full length zipper, mesh back vents and three rear pockets with reflective panels. The women’s Tremola jersey only comes with short sleeves, and costs $119.99. Color options are either black/white or black/pink, and sizes XS-XL are available.skins.netcenter_img The women’s bibshorts are built with SKINS gradient compression, supportive SKINmuscle+ design, SKINdry fabric and the premium women’s chamois. The company designs the SKINfit women’s garments using BMI (body mass index) based calculations to achieve an ergonomic, comfortable fit. Ceramic treated panels are located on the inside of the thighs to reduce friction, and other details include reflective accents, a breathable bib and an elastic hem with silicone grippers.The women’s shorts feature a high waistband for a comfortable fit that also shapes your waistline, but are otherwise identical to the women’s bibs described above. The bibshorts cost $189.99, and the shorts sell for $169.99. Both come in sizes XS-XL, and in black only. The men’s bib longs feature SKINS’ engineered gradient compression and SKINmuscle+ construction to support your muscles during activity. They also feature a premium men’s chamois, SKINdry moisture wicking technology, ceramic treated anti-friction inside leg panels, silicone grippers at the hem, plus mesh inserts and breathable straps to keep you cool. The men’s bibshorts are much the same in materials and features as the bib longs, just with shorter legs. The bib longs sell for $234.99 USD, the shorts cost $194.99, and they come in S-XXL sizes. Black is the only color option.last_img read more

IB14: Bolle’s Premium 6th Sense Cycling Sunglasses, Plus Affordable Italian Made Lifestyle Offerings

first_imgFamed ski goggle manufacturer Bolle had a number of different products on display at their booth at Interbike. Amongst them was their 6th Sense sunglasses, which are their premium cycling offering. The lenses are made from a newer material called Tribex, which is lighter and offers better optics than more common polycarbonate material used in other sports sunglasses.All of Bolle’s lenses meet safety glasses standards for impacts, and are treated with oleophobic and hydrophobic lens coatings. They’re also available in a number of different tints, mirror finishes, or technologies (photochromatic, poloraized, etc…) Depending on lens selection, retail for the sunglasses is $160-200, while replacement lenses run between $55-75. Each frame ships with a side shield which is removable. The shield sits just out of sight and does not actually impair side vision (seriously, I tried them on).The full size frame on the outside, smaller on the insideThe sunglasses have a wire core temple and nose piece, so they can be bent and pinched to achieve the optimal fit.Rather than making a “women’s specific” version of their premiere sunglasses, the company is offering them in two different sizes. The smaller of which has shorter temples. Both will be offered in a wide array of different colors.While Bolle’s first foray into sportswear was in ski goggles, they company is now most famous for their line of sports lifestyle sunglasses. Their range offers an incredible amount of value for the price when compared to Luxottica brands.The frames are all fabricated in Italy and feature unique details and color accents.The lenses are poloraized, and also treated with an oleophobic and hydrophobic coats, to help prevent smudges and water build up (respectively). The full range of sunglasses are currently available on Bolle’s online webstore and at select outdoor retailers.Bollelast_img read more

Registration opens for IRONMAN 70.3 Sunshine Coast

first_img Related IRONMAN, a Wanda Sports Holdings company, has today announced the return of the IRONMAN 70.3 Sunshine Coast triathlon to the heart of Queensland’s Sunshine Coast on Mooloolaba Beach, Australia. After hosting the 2016 IRONMAN 70.3 World Championship, this race course returns for age-group athletes, and will take place on Sunday 10 September 2017.With a location just steps from the beach, and a surfside transition and finish, Mooloolaba Beach offers the ‘perfect year-round climate and relaxing atmosphere for an ideal race destination’. Athletes will tackle a 1.2-mile (1.9 km) ocean swim off Mooloolaba Beach, followed by a flat and fast 56-mile (90 km) bike course, highlighting the region from country to coast. Athletes will then complete a 13.1-mile (21 km), spectator-lined run course on the Mooloolaba Esplanade along striking shores before reaching the finish in the heart of Mooloolaba – all of which must be completed before an eight-and-a-half hour cut-off time.IRONMAN 70.3 Sunshine Coast will offer 30 slots to the 2018 IRONMAN 70.3 World Championship taking place on Saturday 1 September and Sunday 2 September 2018 in Nelson Mandela Bay, South Africa.General registration for IRONMAN 70.3 Sunshine Coast opened today, 9 February read more

Navori Labs and BrightSign Partner to Create New QL Player

first_imgNavori Labs has partnered with BrightSign — designing its QL Player for BrightSign’s 4K and HD digital signage media players — leveraging Navori’s proprietary software and operating system on a standard SD card. The software is available for new BrightSign shipments or as a field upgrade for existing players from 2016 forward, bringing Navori innovations for player synchronization, dynamic data feeds, conditional triggering and more to digital signage networks everywhere.Navori’s QL Player offers several advantages over competitive digital signage player software, including the ability to synchronize content on multiple players and platforms. BrightSign users can now add their media players to an existing network of SoC displays, Android players and PCs, and leverage Navori’s proprietary graphics engine to render all media, including high-resolution content, across one or more displays, video walls, tablets or mobile devices without quality limitations.Navori’s rules-based conditional content triggering capabilities add further value by data-tagging media assets, players and scenarios, and enabling real-time data integration with systems. These applications will allow more flexibility to BrightSign customers aiming to deliver dynamic, targeted content. This includes automatically adapting content to real-time events, including weather conditions, KPI data and inventory levels.Other QL Player for BrightSign software features and benefits include:Full template and ticker design for transparent, multi-layer and multi-zone playbackReliable playout of real-time dynamic data feeds, including social media, XML/RSS, Google Calendar and QL Server hosted dataHTML5-based content managementNavori Labs will demonstrate QL Player for BrightSign on its ISE 2020 stand (8-E212).last_img read more

YLD offers lunchtime webinars

first_imgYLD offers lunchtime webinars The Young Lawyers Division recently launched a new lunchtime webinar series.The initiative aims to offer education and CLE opportunities on topics of particular interest to young lawyers in a convenient format, said YLD President Melanie Griffin, of Orlando, and technology committee Co-Chair Zack Zuroweste, of Clearwater. “This year we decided one of the best ways to meet the needs of young lawyers who may not have one-on-one mentoring or may not have developed the skills they need to practice is through this series,” Griffin said. “Our idea is to offer a webinar bimonthly or monthly on topics such as technology or transitioning to practice.”The webinars are free and offered during the lunch hour.The division’s next webinar, Social Media Ethics: 10 Potential Ethical Pitfalls for Florida Legal Professionals Using Social Media, is set for noon on September 25.The program allows lawyers to earn one general and one ethics CLE credit.Concepts to be covered include legal ethics regulations governing social media, the Rules of Professional Conduct that apply to professional or business activity on social media, and practical considerations lawyers should consider when using social media.Lawyers interested in registering by may do so by visiting the division’s website at, Facebook page at, or Twitter account @flabaryld. Zuroweste said the program, which launched in August with a webinar on using technology to prevent malpractice claims, has been well-received by young lawyers.“Our goal was to exceed 100 people and the first registry had more than 900,” he said. “We’re very excited about that. What it told us is that this is something our members want, and so we are now even more motivated to provide meaningful content.”Griffin said she hopes the webinar series can assist young lawyers as job opportunities for new lawyers shrink.“A large percentage of recent graduates are having significant trouble finding jobs and mentors,” she said. “One thing they’re having to turn to increasingly is hanging out their own shingle. We’re advertising job opportunities when we can, but one of the best things we can do for those who have to open their own practices and hang out their own shingles at early points in their careers is provide them with the education they need to succeed.”Zuroweste said the webinars are designed to apply to a wide range of young lawyers, whether at large or small firms or starting their own practices,“There are a lot of things out there that can get young lawyers in trouble,” he said. “Part of the initiative is to provide content to help those starting out on their own, but the same principles also apply to any young lawyer.”Griffin and Zuroweste said the program is part of the division’s larger initiative to lead the way in incorporating new technology into the practice.“In the last 12 to 24 months, we’ve been tasked with helping to lead the Bar on technology,” Griffin said. “It seemed like an amorphous concept at first and we didn’t know exactly what it meant. With our recent social media campaign, this webinar series, and e-newsletters, we’re really taking tangible steps this year to start actually implementing the technology that’s out there and available to young lawyers and making it meaningful.”Zuroweste agreed.“The practice has changed a lot over the last few years,” he said. “It’s clear technology is going to become an everyday part of the practice of law. It changes the way lawyers talk to each other, interact with each other, and communicate with clients. We think technology is something our group, young lawyers, has an advantage on. We grew up with technology and know it really well. I think we can provide the medium and resources to help young lawyers in the state with the technology that’s out there that can benefit them.” YLD offers lunchtime webinarscenter_img September 15, 2013 Regular Newslast_img read more

“Consult Your Physician Immediately If …”

first_imgThe Huffington Post: It’s difficult to turn on the TV today without seeing an advertisement for one drug or another. That’s not surprising, since drug makers spend billions of dollars each year to promote their treatments for depression, low testosterone, osteoporosis, incontinence, erectile dysfunction, and more. The ad spots are aimed not at physicians but at patients themselves.These ads are required to list the most serious side effects for the prescription drugs they promote, and some are indeed serious — nausea and bleeding and blindness and suicidal thoughts, even death. The warnings are so dire that they must scare some consumers away, yet drug marketers continue to flood the airways.Is that a good marketing strategy? Do consumers take these warnings seriously, and do these frightening catalogs of symptoms change their attitudes toward the drugs? Psychological scientist Ziv Carmon, of INSEAD in Singapore, has been studying the way TV viewers process product warnings — not just for drugs but for cigarettes and artificial sweeteners as well. Working with Yael Steinhart of Tel Aviv University and Yaacov Trope at NYU, Carmon has been exploring how warnings stack up against the seductive benefits that marketers hope for.Read the whole story: The Huffington PostWray Herbert is an author and award-winning journalist who writes two popular blogs for APS, We’re Only Human and Full Frontal Psychology. More of our Members in the Media >last_img read more

News Scan for Feb 17, 2016

first_imgSaudi Arabia reports two MERS cases; US vaccine trial beginsSaudi Arabia’s Ministry of Health (MOH) reported two more MERS cases today, both of which occurred in Riyadh.The first patient is a 53-year-old Saudi man who is in stable condition, the MOH said. The other patient is a 24-year-old foreigner who is hospitalized in an intensive care unit (ICU).The source of both patients’ MERS-CoV (Middle East respiratory syndrome coronavirus) infections is listed as “primary,” indicating no contact with known sources of infection. Neither man is a healthcare worker or had contact with camels.Saudi Arabia’s total of MERS cases since 2012 has reached 1,298, including 740 recoveries, 554 deaths, and 4 patients still receiving treatment, the MOH said.Feb 17 MOH updateIn related news, the first participants in a phase 1 clinical trial to evaluate a MERS-CoV candidate vaccine were vaccinated yesterday, according to a press release from the US Military HIV Research Program (MHRP). The trial will examine the vaccine’s safety and immunogenicity.The trial, which has enrolled 75 participants, is taking place at the Walter Reed Army Institute of Research in Silver Spring, Md. The candidate vaccine, GLS-5300, is manufactured by Inovio Pharmaceuticals and GeneOne Life Science, Inc., and is the first MERS vaccine to be evaluated in humans.Feb 16 MHRP press release Jan 29 CIDRAP News scan on MERS vaccine trial Study details intensive treatment in US, European Ebola patientsEbola patients in the United States and Europe required close monitoring and intensive treatment, but 82% of them survived, according to a study of all 27 US and European patients today in the New England Journal of Medicine.The study comes as the World Health Organization (WHO) today noted no new Ebola cases in West Africa. The agency said in its weekly update that all contacts of the most recent patients in Sierra Leone completed follow-up on Feb 11, but efforts to locate untraced contacts will continue for another week. The most recent cases were confirmed in mid-January.In the study, the Working Group of the US–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the US and Europe noted that the patients who had Ebola virus disease (EVD) ranged from 25 to 75 years old, with a median age of 36. Nineteen (70%) of the patients were men, 9 of 26 patients (35%) had coexisting conditions, and 22 (81%) were healthcare workers.The most common symptoms at illness onset were fatigue (80% of patients) and fever (68%). Nearly all the patients received intravenous fluids and electrolyte supplementation; 9 (33%) required mechanical ventilation; 5 (19%) had continuous renal-replacement therapy; 22 (81%) received antibiotics; and 23 (85%) were prescribed investigational therapies.The investigators noted that serum Ebola viral RNA levels peaked at a median of 7 days after illness onset, and the median time from the onset of symptoms to clearance of virus from the blood was 17.5 days. Five patients died, including 3 who had respiratory and renal failure, for a mortality of 18.5% and survivorship of 81.5%.Feb 17 N Engl J Med studyFeb 17 WHO Ebola update FDA to consider use of skin-infection drug Teflaro in childrenThe US Food and Drug Administration (FDA) has accepted Allergan Plc’s filing of an application to expand the indications for its antibiotic ceftaroline fosamil (Teflaro)—used to treat certain types of skin infections and community-acquired pneumonia—to include children, the Dublin-based company announced yesterday.If Allergan’s supplemental new drug application is approved, the drug’s use will be expanded to include children from the age of 2 months who have acute bacterial skin and skin structure infections (ABSSSI), including those caused by methicillin-resistant Staphylococcus aureus (MRSA), and community-acquired bacterial pneumonia (CABP) caused by Staphylococcus pneumoniae and other designated bacteria, the firm said in a press release.The medication was approved in 2010 for adults with ABSSSI and CABP caused by certain susceptible bacteria. Allergan said ceftaroline fosamil is a cephalosporin with activity against both gram-positive and gram-negative pathogens.David Nicholson, PhD, Allergan’s executive vice president, said ABSSSI and CABP have a significant impact among children, especially those under 5 years old. “This acceptance brings us one step closer to providing another choice for physicians to properly treat pediatric patients with ABSSSI and CABP, including those infections caused by difficult-to-treat pathogens,” he said.The company said its application was based on the results of five clinical studies of Teflaro in pediatric patients, including one active-controlled study in children with ABSSSI, two active-controlled studies in patients with CABP, and two pharmacokinetic studies.Feb 16 Allergan press releaselast_img read more